NO974490L - Inhibering av C.difficile-infeksjoner ved ufordöyelige oligosakkarider - Google Patents

Inhibering av C.difficile-infeksjoner ved ufordöyelige oligosakkarider

Info

Publication number
NO974490L
NO974490L NO974490A NO974490A NO974490L NO 974490 L NO974490 L NO 974490L NO 974490 A NO974490 A NO 974490A NO 974490 A NO974490 A NO 974490A NO 974490 L NO974490 L NO 974490L
Authority
NO
Norway
Prior art keywords
difficile
indigestible oligosaccharides
diarrhea
microflora
inhibit
Prior art date
Application number
NO974490A
Other languages
English (en)
Other versions
NO313685B1 (no
NO974490D0 (no
Inventor
Keith Allen Garleb
Brian Warren Wolf
Jonathan Allan Meulbroek
Keith Brian Wheeler
Shelia Martinson Campbell
Joseph Edward Walton
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/417,413 external-priority patent/US5688777A/en
Priority claimed from US08/417,411 external-priority patent/US5733579A/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO974490L publication Critical patent/NO974490L/no
Publication of NO974490D0 publication Critical patent/NO974490D0/no
Publication of NO313685B1 publication Critical patent/NO313685B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
NO19974490A 1995-04-05 1997-09-29 Oral rehydreringslösning NO313685B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/417,413 US5688777A (en) 1995-04-05 1995-04-05 Inhibition of C. difficile infections by indigestible oligosaccharides
US08/417,411 US5733579A (en) 1995-04-05 1995-04-05 Oral rehydration solution containing indigestible oligosaccharides
PCT/US1996/004665 WO1996031219A1 (en) 1995-04-05 1996-04-04 Inhibition of c. difficile infections by indigestible oligosaccharides

Publications (3)

Publication Number Publication Date
NO974490L true NO974490L (no) 1997-09-29
NO974490D0 NO974490D0 (no) 1997-09-29
NO313685B1 NO313685B1 (no) 2002-11-18

Family

ID=27023728

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19974490A NO313685B1 (no) 1995-04-05 1997-09-29 Oral rehydreringslösning

Country Status (14)

Country Link
EP (1) EP0820292B1 (no)
JP (1) JPH11503168A (no)
AT (1) ATE232389T1 (no)
AU (1) AU704004B2 (no)
CA (1) CA2217157C (no)
DE (1) DE69626200T2 (no)
DK (1) DK0820292T3 (no)
ES (1) ES2194988T3 (no)
HK (1) HK1008492A1 (no)
MX (1) MX9707631A (no)
NO (1) NO313685B1 (no)
NZ (1) NZ306712A (no)
PT (1) PT820292E (no)
WO (1) WO1996031219A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60031385D1 (de) * 2000-06-28 2006-11-30 B S D Bio Science Dev Snc Di O Pharmazeutische Zusammensetzungen von Antibiotika und Fruktan-Gemische
EP1243273A1 (en) † 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
US20110245171A1 (en) * 2004-09-30 2011-10-06 Hardin James A Rehydration compositions comprising epidermal growth factor (egf)
EP2117355B1 (en) * 2007-03-13 2017-04-26 N.V. Nutricia Method of improving skills with a composition comprising non-digestible saccharide
CN109069521A (zh) * 2016-03-14 2018-12-21 物产食品科技股份有限公司 粪杆菌属细菌增殖剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902674A (en) * 1987-10-13 1990-02-20 Coors Biotech, Inc. Method for inhibiting the growth of salmonella
IE81127B1 (en) * 1989-02-07 2000-03-22 Dimminaco Ag Effervescent composition for oral rehydration
US5397786A (en) * 1993-01-08 1995-03-14 Simone; Charles B. Rehydration drink

Also Published As

Publication number Publication date
DE69626200D1 (de) 2003-03-20
NO313685B1 (no) 2002-11-18
AU704004B2 (en) 1999-04-01
HK1008492A1 (en) 1999-05-14
EP0820292A1 (en) 1998-01-28
PT820292E (pt) 2003-06-30
CA2217157C (en) 2002-07-30
ES2194988T3 (es) 2003-12-01
WO1996031219A1 (en) 1996-10-10
NZ306712A (en) 1999-10-28
AU5534296A (en) 1996-10-23
CA2217157A1 (en) 1996-10-10
JPH11503168A (ja) 1999-03-23
NO974490D0 (no) 1997-09-29
DE69626200T2 (de) 2003-12-18
MX9707631A (es) 1998-04-30
ATE232389T1 (de) 2003-02-15
EP0820292B1 (en) 2003-02-12
DK0820292T3 (da) 2003-05-19

Similar Documents

Publication Publication Date Title
ES2091290T3 (es) Tratamiento para la diarrea por clostridium difficile y colitis pseudomembranosa.
GEP20012415B (en) THF-Containing Sulfonamide Inhibitors of Aspartyl Protease
AU5669198A (en) Cyclosporin derivative, its preparation and pharmaceutical compositions containing same
ATE242216T1 (de) Tricyclische verbindungen als inhibitoren von farnesyl protein transferase
NO20002595D0 (no) Anvendelse av en ringsystemforbindelse for fremstilling av et medikament
TR199700660T1 (xx) Yeni farnezil transferaz �nleyiciler.
IE821129L (en) Cephalosporins
TW337977B (en) Low VOC liquid formulations of 1, 2-benzisothiazolin-3-one and method of manufacture
DE69631609D1 (en) Tricyclische erythromycinderivate
NO974490L (no) Inhibering av C.difficile-infeksjoner ved ufordöyelige oligosakkarider
EP1089740B8 (en) Compositions for the treatment of cdad initiated by c. difficile toxin b
MX9708611A (es) Compuestos de dialquiltiacumicina.
WO1995030439A3 (en) Prevention of tumor metastasis
ES479636A1 (es) Procedimiento para la obtencion de un antibiotico de efecto sinergistico.
TW325997B (en) Pharmaceutical composition for preventing and treating retinal diseases
DE3260277D1 (en) Peptide antibiotic, component b, process for its preparation and its use in medicines
CA2293358A1 (en) Tricyclic sulfonamide inhibitors of farnesyl-protein transferase
PL307864A1 (en) Retroviral infection inhibition
NO961900L (no) Metylenblått for behandling eller profylakse av encefalopati forårsaket av ifosfamid
GR79420B (no)
NO944246L (no) Halogenerte 4'-metoksyacetofenoner som mikrobicider og preserveringsmidler
ES546915A0 (es) Procedimiento para preparar nuevos antibioticos policiclicos por fermentacion de una cepa de actinomadura melliaura.
BG102014A (en) Carbapenem esters
ECSP982677A (es) Fosfato de tetrahidrofurano antifungal